Terms: = Breast cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310 AND Treatment
11 results:
1. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal cancer.
Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
[TBL] [Abstract] [Full Text] [Related]
2. Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human breast cancer.
Liao TT; Han JF; Zhang FY; Na R; Ye WL
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885691
[TBL] [Abstract] [Full Text] [Related]
3. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
[TBL] [Abstract] [Full Text] [Related]
4. ubr5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
[TBL] [Abstract] [Full Text] [Related]
5. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.
Song M; Wang C; Wang H; Zhang T; Li J; Benezra R; Chouchane L; Sun YH; Cui XG; Ma X
Oncoimmunology; 2020; 9(1):1746148. PubMed ID: 32363114
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
Khalid S; Hanif R; Jabeen I; Mansoor Q; Ismail M
PLoS One; 2018; 13(5):e0196312. PubMed ID: 29787591
[TBL] [Abstract] [Full Text] [Related]
7. E3 Ubiquitin Ligase ubr5 Drives the Growth and Metastasis of Triple-Negative breast cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract] [Full Text] [Related]
8. Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.
Abdelsamie AS; Bey E; Gargano EM; van Koppen CJ; Empting M; Frotscher M
Eur J Med Chem; 2015 Oct; 103():56-68. PubMed ID: 26322835
[TBL] [Abstract] [Full Text] [Related]
9. Progestin-inducible edd E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac.
McDonald WJ; Thomas LN; Koirala S; Too CKL
Mol Cell Endocrinol; 2014 Jan; 382(1):254-261. PubMed ID: 24145130
[TBL] [Abstract] [Full Text] [Related]
10. hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1).
Spadaro A; Negri M; Marchais-Oberwinkler S; Bey E; Frotscher M
PLoS One; 2012; 7(1):e29252. PubMed ID: 22242164
[TBL] [Abstract] [Full Text] [Related]
11. Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin.
Doroshow JH; Synold TW; Somlo G; Akman SA; Gajewski E
Blood; 2001 May; 97(9):2839-45. PubMed ID: 11313279
[TBL] [Abstract] [Full Text] [Related]
